Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence.

PubWeight™: 5.54‹?› | Rank: Top 1%

🔗 View Article (PMC 2933747)

Published in Nicotine Tob Res on November 01, 2007

Authors

Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, Timothy B Baker, Megan E Piper, Danielle E McCarthy, Daniel M Bolt, Stevens S Smith, Su-Young Kim, Suzanne Colby, David Conti, Gary A Giovino, Dorothy Hatsukami, Andrew Hyland, Suchitra Krishnan-Sarin, Raymond Niaura, Kenneth A Perkins, Benjamin A Toll

Articles citing this

(truncated to the top 100)

Tobacco addiction. Lancet (2008) 3.65

The reliability and predictive validity of the Heaviness of Smoking Index and its two components: findings from the International Tobacco Control Four Country study. Nicotine Tob Res (2010) 2.34

Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. JAMA (2016) 2.31

Did hardening occur among smokers in England from 2000 to 2010? Addiction (2013) 2.14

Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry (2012) 2.02

Clinical practice. Treating smokers in the health care setting. N Engl J Med (2011) 1.99

Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation. Prev Med (2014) 1.88

Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol (2008) 1.86

Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res (2009) 1.84

DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction (2012) 1.81

Time to first cigarette after waking predicts cotinine levels. Cancer Epidemiol Biomarkers Prev (2009) 1.69

Time to smoke first morning cigarette and lung cancer in a case-control study. J Natl Cancer Inst (2014) 1.66

Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res (2008) 1.62

Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol (2010) 1.60

Financial incentives for smoking cessation in pregnancy: a single-arm intervention study assessing cessation and gaming. Addiction (2015) 1.58

The hardening hypothesis: is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary. Drug Alcohol Depend (2011) 1.57

Tobacco dependence among intermittent smokers. Nicotine Tob Res (2012) 1.54

Evaluation of EX: a national mass media smoking cessation campaign. Am J Public Health (2010) 1.48

Smoker characteristics and smoking-cessation milestones. Am J Prev Med (2011) 1.47

Associations of mindfulness with nicotine dependence, withdrawal, and agency. Subst Abus (2009) 1.35

On the nature of nicotine addiction: a taxometric analysis. J Abnorm Psychol (2008) 1.25

Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet Genomics (2013) 1.24

Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nicotine Tob Res (2014) 1.23

A ban on menthol cigarettes: impact on public opinion and smokers' intention to quit. Am J Public Health (2012) 1.23

Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer (2009) 1.23

A systematic review of the relationships between craving and smoking cessation. Nicotine Tob Res (2013) 1.21

The Wisconsin Predicting Patients' Relapse questionnaire. Nicotine Tob Res (2009) 1.20

Time-varying processes involved in smoking lapse in a randomized trial of smoking cessation therapies. Nicotine Tob Res (2014) 1.19

Bupropion for smoking cessation in African American light smokers: a randomized controlled trial. J Natl Cancer Inst (2012) 1.17

Dissection of the phenotypic and genotypic associations with nicotinic dependence. Nicotine Tob Res (2011) 1.09

Smoking Cessation Intervention on Facebook: Which Content Generates the Best Engagement? J Med Internet Res (2015) 1.08

Diffusion of an evidence-based smoking cessation intervention through Facebook: a randomised controlled trial study protocol. BMJ Open (2014) 1.07

Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives: II. Evidence from a laboratory self-administration assay. J Abnorm Psychol (2010) 1.06

Give It Up For Baby: outcomes and factors influencing uptake of a pilot smoking cessation incentive scheme for pregnant women. BMC Public Health (2013) 1.06

Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial. JAMA Psychiatry (2014) 1.06

Predictors of persistent nicotine dependence among adults in the United States. Drug Alcohol Depend (2011) 1.06

Do smokers crave cigarettes in some smoking situations more than others? Situational correlates of craving when smoking. Nicotine Tob Res (2010) 1.05

Behavioral filter vent blocking on the first cigarette of the day predicts which smokers of light cigarettes will increase smoke exposure from blocked vents. Exp Clin Psychopharmacol (2009) 1.05

A mixed-methods study of young adults' receptivity to using Facebook for smoking cessation: if you build it, will they come? Am J Health Promot (2014) 1.04

Sex differences in negative affect and lapse behavior during acute tobacco abstinence: a laboratory study. Exp Clin Psychopharmacol (2013) 1.04

Developing and validating a human laboratory model to screen medications for smoking cessation. Nicotine Tob Res (2012) 1.03

Individual, social, and environmental factors associated with support for smoke-free housing policies among subsidized multiunit housing tenants. Nicotine Tob Res (2012) 1.02

Randomized trial of telephone-delivered acceptance and commitment therapy versus cognitive behavioral therapy for smoking cessation: a pilot study. Nicotine Tob Res (2014) 1.01

Within-day temporal patterns of smoking, withdrawal symptoms, and craving. Drug Alcohol Depend (2011) 1.01

Evaluation of a hospital-based tobacco treatment service: outcomes and lessons learned. J Hosp Med (2010) 1.00

Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence. J Abnorm Psychol (2012) 1.00

Associations between health literacy and established predictors of smoking cessation. Am J Public Health (2013) 1.00

Nicotine dependence phenotype and lung cancer risk. Cancer (2011) 1.00

Understanding the role of cessation fatigue in the smoking cessation process. Drug Alcohol Depend (2013) 1.00

WISDM primary and secondary dependence motives: associations with self-monitored motives for smoking in two college samples. Drug Alcohol Depend (2010) 1.00

Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. Psychopharmacology (Berl) (2011) 0.99

Point process analyses of variations in smoking rate by setting, mood, gender, and dependence. Psychol Addict Behav (2011) 0.99

Relations of alcohol consumption with smoking cessation milestones and tobacco dependence. J Consult Clin Psychol (2012) 0.98

Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence. Addict Behav (2010) 0.98

Tobacco control environment in the United States and individual consumer characteristics in relation to continued smoking: differential responses among menthol smokers? Prev Med (2014) 0.97

Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers. J Psychopharmacol (2012) 0.97

Dependence and withdrawal-induced craving predict abstinence in an incentive-based model of smoking relapse. Nicotine Tob Res (2012) 0.96

Development and reliability of the lifetime interview on smoking trajectories. Nicotine Tob Res (2011) 0.96

Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res (2011) 0.96

Individual and family factors associated with intention to quit among male Vietnamese American smokers: implications for intervention development. Addict Behav (2010) 0.95

The reinforcement threshold for nicotine as a target for tobacco control. Drug Alcohol Depend (2012) 0.94

The Smoking Consequences Questionnaire: Factor structure and predictive validity among Spanish-speaking Latino smokers in the United States. Nicotine Tob Res (2009) 0.93

The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race. Psychopharmacology (Berl) (2014) 0.93

A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. J Thorac Oncol (2011) 0.93

Modeling complexity of EMA data: time-varying lagged effects of negative affect on smoking urges for subgroups of nicotine addiction. Nicotine Tob Res (2013) 0.93

Tobacco Use, Quitting Behavior, and Health Characteristics Among Current Electronic Cigarette Users in a National Tri-Ethnic Adult Stable Smoker Sample. Nicotine Tob Res (2014) 0.92

Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures. Psychol Assess (2009) 0.92

Severity of tobacco abstinence symptoms varies by time of day. Nicotine Tob Res (2009) 0.92

Effects of duration of electronic cigarette use. Nicotine Tob Res (2014) 0.92

Genomics and personalized medicine: CHRNA5-CHRNA3-CHRNB4 and smoking cessation treatment. J Food Drug Anal (2013) 0.91

Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence. Transl Psychiatry (2015) 0.90

Feasibility and Quit Rates of the Tobacco Status Project: A Facebook Smoking Cessation Intervention for Young Adults. J Med Internet Res (2015) 0.90

Prevalence and Frequency of mHealth and eHealth Use Among US and UK Smokers and Differences by Motivation to Quit. J Med Internet Res (2015) 0.90

Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study. Drug Alcohol Depend (2011) 0.90

Smoking antecedents: separating between- and within-person effects of tobacco dependence in a multiwave ecological momentary assessment investigation of adolescent smoking. Nicotine Tob Res (2013) 0.89

Development of the PROMIS nicotine dependence item banks. Nicotine Tob Res (2014) 0.89

Impact of tobacco control policy on quitting and nicotine dependence among women in five European countries. Tob Control (2012) 0.89

Anhedonia as a component of the tobacco withdrawal syndrome. J Abnorm Psychol (2014) 0.89

Young adults who smoke cigarettes and marijuana: analysis of thoughts and behaviors. Addict Behav (2013) 0.89

Time to first cigarette predicts cessation outcomes in adolescent smokers. Nicotine Tob Res (2013) 0.88

Resting-state functional connectivity and nicotine addiction: prospects for biomarker development. Ann N Y Acad Sci (2015) 0.88

Heaviness of smoking predicts smoking relapse only in the first weeks of a quit attempt: findings from the International Tobacco Control Four-Country Survey. Nicotine Tob Res (2013) 0.87

A latent class analysis of DSM-IV and Fagerström (FTND) criteria for nicotine dependence. Nicotine Tob Res (2011) 0.87

Tobacco quitlines need to assess and intervene with callers' hazardous drinking. Alcohol Clin Exp Res (2012) 0.87

Linking measures of adult nicotine dependence to a common latent continuum and a comparison with adolescent patterns. Drug Alcohol Depend (2011) 0.86

Gold standard program for heavy smokers in a real-life setting. Int J Environ Res Public Health (2013) 0.85

Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant. Nicotine Tob Res (2012) 0.85

Assessment of variables associated with smoking cessation in Crohn's disease. Dig Dis Sci (2012) 0.85

A cross-sectional study on tobacco use and dependence among women: Does menthol matter? Tob Induc Dis (2012) 0.85

What aspect of dependence does the fagerström test for nicotine dependence measure? ISRN Addict (2012) 0.84

The relationship of childhood trauma to nicotine dependence in pregnant smokers. Psychol Addict Behav (2011) 0.84

Comparison of the cigarette dependence scale with four other measures of nicotine involvement: correlations with smoking history and smoking treatment outcome in smokers with substance use disorders. Addict Behav (2013) 0.84

A pilot study of pain-related anxiety and smoking-dependence motives among persons with chronic pain. Exp Clin Psychopharmacol (2013) 0.84

The nicotine dependence phenotype, time to first cigarette, and larynx cancer risk. Cancer Causes Control (2012) 0.83

Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report. Nicotine Tob Res (2012) 0.83

Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort. Am J Med Genet B Neuropsychiatr Genet (2012) 0.83

Cues must increase smoking behaviour to be clinically relevant. Addiction (2009) 0.83

Menthol smoking in relation to time to first cigarette and cotinine: results from a community-based study. Regul Toxicol Pharmacol (2012) 0.83

Nicotine dependence phenotype, time to first cigarette, and risk of head and neck cancer. Cancer (2011) 0.82

Contingent vouchers and motivational interviewing for cigarette smokers in residential substance abuse treatment. J Subst Abuse Treat (2015) 0.82

Articles cited by this

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91

Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA (1994) 17.56

Biochemical verification of tobacco use and cessation. Nicotine Tob Res (2002) 14.54

Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict (1989) 11.63

Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev (2004) 9.30

Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav (1978) 9.23

Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med (1989) 8.95

The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res (2004) 5.72

Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 5.63

Methods used to quit smoking in the United States. Do cessation programs help? JAMA (1990) 5.57

A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol (2004) 4.24

Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend (1994) 4.15

Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med (2004) 3.26

Smoking patterns and dependence: contrasting chippers and heavy smokers. J Abnorm Psychol (2006) 3.20

Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med (2002) 2.98

Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health (2000) 2.78

Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res (2006) 2.77

Dynamic self-efficacy and outcome expectancies: prediction of smoking lapse and relapse. J Abnorm Psychol (2005) 2.67

Progression from a smoking lapse to relapse: prediction from abstinence violation effects, nicotine dependence, and lapse characteristics. J Consult Clin Psychol (1996) 2.32

Validation of the modified Fagerström tolerance questionnaire with salivary cotinine among adolescents. Addict Behav (2000) 2.16

Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependence. Addict Behav (2003) 2.07

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry (2006) 1.89

Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Arch Intern Med (1997) 1.83

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med (2006) 1.78

Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict Behav (1999) 1.68

Nicodermal patch adherence and its correlates. Drug Alcohol Depend (1999) 1.57

A study of the psychometric and predictive properties of the Fagerström Test for Nicotine Dependence in a population of young smokers. Nicotine Tob Res (1999) 1.51

Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med (1996) 1.43

Individual differences in the context of smoking lapse episodes. Addict Behav (1998) 1.35

A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. Drug Alcohol Depend (2005) 1.35

Individual differences in smoking: gender and nicotine addiction. Nicotine Tob Res (1999) 1.32

Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. Addiction (2007) 1.29

Assessing the generalizability of smoking studies. Addiction (1997) 1.17

Data to estimate the similarity of tobacco research samples to intended populations. Nicotine Tob Res (2004) 1.15

Behavioral treatment for smokers with a history of alcoholism: predictors of successful outcome. J Consult Clin Psychol (2001) 0.98

Articles by these authors

Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet (2006) 13.16

Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev (2004) 9.30

Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet (2006) 7.90

Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry (2008) 6.73

Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med (2013) 6.35

A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A (2010) 4.94

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry (2009) 4.66

A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol (2004) 4.24

Sibling effects on smoking in adolescence: evidence for social influence from a genetically informative design. Addiction (2005) 4.01

The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev (2004) 3.80

Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res (2004) 3.78

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) (2002) 3.74

Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health (2004) 3.71

Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) (2006) 3.68

Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial. J Natl Cancer Inst (2004) 3.26

A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet (2008) 3.25

Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet (2012) 3.19

The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tob Control (2009) 3.10

Smoking cessation treatment on the Internet: content, quality, and usability. Nicotine Tob Res (2004) 3.06

A longitudinal assessment of the impact of smoke-free worksite policies on tobacco use. Am J Public Health (2005) 3.05

Tobacco industry marketing at point of purchase after the 1998 MSA billboard advertising ban. Am J Public Health (2002) 3.04

Smoking during pregnancy and newborn neurobehavior. Pediatrics (2003) 2.93

Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res (2004) 2.89

New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res (2008) 2.89

Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry (2014) 2.88

Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet (2009) 2.86

Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res (2006) 2.77

Do cigarette prices motivate smokers to quit? New evidence from the ITC survey. Addiction (2010) 2.68

Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents. Nicotine Tob Res (2004) 2.66

Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res (2006) 2.65

Prevalence and predictors of transitions in smoking behavior among college students. Health Psychol (2004) 2.64

Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tob Res (2004) 2.63

The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res (2009) 2.63

Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev (2005) 2.59

Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am J Public Health (2007) 2.52

Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract (2005) 2.51

Have we lost our way? The need for dynamic formulations of smoking relapse proneness. Addiction (2002) 2.48

Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res (2008) 2.47

Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet (2011) 2.47

Stress response and the adolescent transition: performance versus peer rejection stressors. Dev Psychopathol (2009) 2.46

Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome. Addict Behav (2005) 2.45

New methods for tobacco dependence treatment research. Ann Behav Med (2011) 2.44

The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med (2011) 2.43

Nicotine reduction revisited: science and future directions. Tob Control (2010) 2.41

Predictors of smoking relapse by duration of abstinence: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction (2009) 2.36

Access to low-taxed cigarettes deters smoking cessation attempts. Am J Public Health (2005) 2.33

Menstrual phase effects on smoking relapse. Addiction (2008) 2.33

Cigarette purchasing behaviors when prices are high. J Public Health Manag Pract (2005) 2.33

Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol (2006) 2.30

Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry (2008) 2.29

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry (2005) 2.28

Characteristics of smokers reached and recruited to an internet smoking cessation trial: a case of denominators. Nicotine Tob Res (2006) 2.28

Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry (2009) 2.25

Cataract surgery in eyes with nanophthalmos and relative anterior microphthalmos. Am J Ophthalmol (2012) 2.21

Proximal versus distal cues to smoke: the effects of environments on smokers' cue-reactivity. Exp Clin Psychopharmacol (2008) 2.18

Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol (2002) 2.18

How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction (2012) 2.13

How did UK cigarette makers reduce tar to 10 mg or less? BMJ (2006) 2.10

Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav (2013) 2.07

Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry (2012) 2.02

Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention. Nicotine Tob Res (2006) 2.02

Use of flavored cigarettes among older adolescent and adult smokers: United States, 2004--2005. Nicotine Tob Res (2008) 2.01

Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci (2006) 1.99

Clinical practice. Treating smokers in the health care setting. N Engl J Med (2011) 1.99

Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry (2003) 1.95

Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med (2009) 1.95

Modeling the effect of alcohol on smoking lapse behavior. Psychopharmacology (Berl) (2006) 1.95

An assessment of the effect of data collection setting on the prevalence of health risk behaviors among adolescents. J Adolesc Health (2002) 1.91

Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend (2004) 1.91

Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med (2005) 1.90

Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. J Pediatr (2008) 1.88

A prospective examination of distress tolerance and early smoking lapse in adult self-quitters. Nicotine Tob Res (2009) 1.87

History of depression and smoking cessation outcome: a meta-analysis. J Consult Clin Psychol (2003) 1.86

State tobacco control spending and youth smoking. Am J Public Health (2005) 1.86

Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol (2008) 1.86

Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res (2009) 1.84